Cross-agency comparison: 🇨🇦 Health Canada leads with 22 documents in 90 days

FDA vs EMA vs MHRA vs Health Canada — who's most active?

The recent regulatory output suggests that Health Canada, the FDA, and the MHRA are currently more active compared to the EMA, which reported no documents in the same timeframe. This may indicate a more dynamic regulatory environment in North America and the UK, potentially leading sponsors to prioritize submissions in these regions. Companies should consider allocating resources strategically to align with this activity, possibly expediting their filing processes in Canada and the U.S. while remaining cautious about timelines in the European market.